Scarica l'app Stockscreener
53.82
0.92%
0.49
Dopo l'orario di chiusura:
53.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRUS Giù?
Forum
Previsione
Merus N V Borsa (MRUS) Ultime notizie
Merus gains after mid-stage trial data for lead asset in head and neck cancer - MSN
(MRUS) Technical Data - news.stocktradersdaily.com
Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential By Investing.com - Investing.com South Africa
Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential - Investing.com Nigeria
Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus (NASDAQ:BCAX) - Seeking Alpha
The Netherlands: Merus raises US$300m from underwritten public offering - Investors in Healthcare
Why Merus N.V. (MRUS) Crashed On Wednesday - MSN
Merus N.V. announces proposed public offering of common shares - MSN
Merus dips 7%, prices $300M stock at $57 per share - MSN
Merus Announces Public Offering of Common Shares - TipRanks
Merus Raises $300m After ASCO Success - insights.citeline.com
Sector Update: Health Care Stocks Mixed Premarket Wednesday - marketscreener.com
MRUS: Joint Managers Lead Successful Offering | MRUS Stock News - GuruFocus
Merus Prices $300 Million Stock Offering - marketscreener.com
Merus N.V. (MRUS) Launches $300M Public Offering - GuruFocus
Merus N.V. announces public offering of common shares By Investing.com - Investing.com South Africa
Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln - Nasdaq
Merus N.V. Announces Pricing of Public Offering of Common Shares - The Manila Times
Merus N.V. Announces Proposed Public Offering of Common Shares | - GuruFocus
Merus (MRUS) Initiates Public Offering to Fund Development | MRU - GuruFocus
Merus (MRUS) Initiates Public Offering to Fund Development | MRUS Stock News - GuruFocus
Merus N.V. announces public offering of common shares - Investing.com Australia
Merus Plans Public Share Offering - marketscreener.com
Drugmaker Merus slips after share offering launch - TradingView
Merus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewswire
How to Take Advantage of moves in (MRUS) - news.stocktradersdaily.com
e.l.f Beauty, Box And Joby Aviation Are Among Top 11 Mid-Cap Gainers Last Week (May 26-May 30): Are Others In Your Portfolio? - Benzinga
Merus, N.V. Provides Updates on Clinical Development - marketscreener.com
Merus NV Stock Skyrockets 8%: Bull Run Intact or Peak Approaching? - Daily Chhattisgarh News
Merus Announces Promising Phase 2 Trial Results - TipRanks
ASCO25: Merus wins in head-to-head with Bicara for head and neck cancer - Yahoo Finance
Merus to Present at Upcoming Investor Conferences - GlobeNewswire
Merus Showcases Next-Gen Cancer Antibody Platform at Two Premier Healthcare Conferences - Stock Titan
Merus stock holds $85 target, Buy rating at H.C. Wainwright - Investing.com
Merus stock holds $85 target, Buy rating at H.C. Wainwright By Investing.com - Investing.com India
Merus (MRUS) Stock: Analysts Rally Behind Biotech After Cancer Treatment Breakthrough - CoinCentral
Merus (NASDAQ:MRUS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Merus (NASDAQ:MRUS) Given a $110.00 Price Target by BMO Capital Markets Analysts - Defense World
Lazard Asset Management LLC Takes Position in Merus (NASDAQ:MRUS) - Defense World
Merus (NASDAQ:MRUS) Price Target Raised to $110.00 - Defense World
BofA Maintains Buy Rating on Merus (MRUS), Lifts PT - Yahoo Finance
Merus N.V.’s SWOT analysis: promising cancer drug pipeline boosts stock outlook - Investing.com Australia
Merus (MRUS) Price Target Raised at BMO After Positive Phase 2 Data - MSN
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):